1.
Surg Oncol Clin N Am
; 13(4): 697-709, x, 2004 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-15350943
RESUMEN
The authors developed a strategy that includes a novel approach of induction full-dose chemotherapy followed by traditional chemoradiation as a neoadjuvant therapy for pancreatic cancer. Here they report the results of a phase I/II trial of gemcitabine, cisplatin, and 5-FU for patients with advanced gastrointestinal malignancies.